$30 Billion Sleep Market Is A Mixed Bag During The Pandemic

   May 27, 2021…  Marketdata LLC, a leading independent market research publisher of “off-the-shelf” studies about service industries since 1979, has released a new 177-page report entitled:   The Sleep Market: Sleep Labs, Bedding, CPAPs, Drugs & More  This new Marketdata study examines the “sleep” market and its components, covering markets for: anti-insomnia medications and OTC supplements, sleep labs, mattresses and pillows, CPAPs (continuous positive airway pressure devices, for those with sleep apnea), and retail sleep aids (earplugs, sleep lamps, sound machines, eye masks, books, smartphone apps).
 
According to Research Director, John LaRosa:  “As obesity rates climb and Americans age, more people are developing sleep apnea and other sleep disorders. Plus, stress in 2020 related to the presidential election, Covid-19 pandemic and recession are all contributing to more sleepless nights. As a result, a major industry has emerged to analyze and treat America’s insomniacs--sleep labs, home sleep studies, CPAP devices, premium mattresses and pillows, OTC supplements and Rx drugs, apps, sound machines, and more.”

Major Report Findings:

* Market Size & Growth…. Marketdata estimates that the U.S. sleep market was worth $30.66 billion in 2019, up 3.0% from the prior year. The market barely inched up 0.1% in value, to $30.7 billion in 2020, but the total market is forecast to grow 4.8% this year, to a value of $32.1 billion.

* The Prescription Insomnia Drugs market, led by Belsomra, Ambien/Zolpidem, and Lunesta, has been declining in value due to the expiration of patents and the entry of cheaper generics. However, sales of OTC supplements such as Melatonin are growing strongly. The total market for Rx and OTC sleep “drugs” is estimated at $2.1 billion in 2020.

 * Sleep Centers…. There was a major shift in the mix of in-center vs. at-home sleep studies performed by sleep centers during 2020—from 70% in-house/30% at-home to 30% in-house/70% at-home. This shift to telemedicine, coupled with center closures and lower patient volumes, caused revenues to fall by 27%, to $3.1 billion. A partial rebound is forecast in 2021. There are an estimated 4,400 U.S. sleep labs.

 * CPAP devices – A significant market segment and the one with the highest current growth rates is the CPAP devices market—continuous positive airway pressure devices used for persons with obstructive sleep apnea. This industry remains less than 10% penetrated on a global basis. The market was worth $6.47 billion in 2020, representing a strong 15% gain.

 * With consumers more focused than ever last year on comfort and improving their sleep quality, Mattress sales held up well, growing by 1.2% to $16.9 billion in retail sales. This market is being disrupted by makers such as Casper and Purple, that have ditched the retail showroom and deliver directly to the customer’s home.

* The Sleep Pillows Market.…  is worth $1.88 billion and is also growing, as new materials and premium-priced and “smart” pillows sell well.

 About The Report

The U.S. Sleep Market: Sleep Labs, Bedding, CPAPs, Drugs & More,  published in May 2021, is an independently researched  market  research study.  It contains 43 tables and is 177 pages long.  10 In-depth competitor profiles are included. It costs $1,495, but is sold by individual chapters at lower cost.  A detailed Table of Contents is available by email:  A 37-page $99 Overview Summary is available. Contact:  John LaRosa, Marketdata LLC, 7210 Wareham Drive, Tampa, FL 33647, 813-971-8080, or: see the website: www.marketdataenterprises.com.

About Marketdata LLC

Marketdata is 42-year old independent market research report publisher and consulting firm. It specializes in tracking a variety of personal service and healthcare sectors, and emerging niche markets.

Contact Information

John LaRosa

Research Director

Marketdata LLC

(1) 8139718080

marketdataent@yahoo.com